Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis b virus infection

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Pan, Ning ^a,b   Qiu, Jie ^b,c   Sun, Hang ^b   Miao, Fengqin ^a,b   Shi, Qian ^b   Xu, Jinhuan ^b   Jiang, Wei ^b   Jin, Hui ^b   Xie, Wei ^a,b   He, Youji ^a   Zhang, Jianqiong ^a,b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Nanjing Second Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; LIGAND;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HLA A ANTIGEN GENE; HLA ANTIGEN GENE; HLA B ANTIGEN GENE; HLA C ANTIGEN GENE; HLA SYSTEM; HUMAN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2 GENE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; ALLELE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; SEX DIFFERENCE;

ADULT; AGE OF ONSET; ALLELES; CARCINOMA, HEPATOCELLULAR; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HLA ANTIGENS; HUMANS; LIGANDS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, KIR; SEX FACTORS;

EID: 84890098106     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/874514     Document Type: Article

References (37)

1. El-Serag H. B., Hepatocellular carcinoma. The New England Journal of Medicine 2011 365 12 1118 1127 2-s2.0-80053088189 10.1056/NEJMra1001683
2. McMahon B. J., Bulkow L., Harpster A., Snowball M., Lanier A., Sacco F., Dunaway E., Williams J., Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000 32 4 I 842 846 2-s2.0-0033798307
3. Zhang B., Yang B., Tang Z., Randomized controlled trial of screening for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2004 130 7 417 422 2-s2.0-3843125293 (Pubitemid 39044345)
4. Amarapurkar D., Han K., Chan H. L., Ueno Y., Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Journal of Gastroenterology and Hepatology 2009 24 6 955 961 2-s2.0-66549114663 10.1111/j.1440-1746.2009.05805.x
5. Farrell G., Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Journal of Gastroenterology and Hepatology 2010 25 4 657 663 2-s2.0-77950136782 10.1111/j.1440-1746.2009.06167.x
6. Tian Z., Chen Y., Gao B., Natural killer cells in liver disease. Hepatology 2013 57 4 1654 1662
7. Dunn C., Brunetto M., Reynolds G., Christophides T., Kennedy P. T., Lampertico P., Das A., Lopes A. R., Borrow P., Williams K., Humphreys E., Afford S., Adams D. H., Bertoletti A., Maini M. K., Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. Journal of Experimental Medicine 2007 204 3 667 680 2-s2.0-33947411395 10.1084/jem.20061287 (Pubitemid 46457088)
8. Chen Y., Sun R., Jiang W., Wei H., Tian Z., Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN- γ -dependent manner. Journal of Hepatology 2007 47 2 183 190 2-s2.0-34347407333 10.1016/j.jhep.2007.02.020 (Pubitemid 47021249)
9. Trachtenberg E., Vinson M., Hayes E., Hsu Y.-M., Houtchens K., Erlich H., Klitz W., Hsia Y., Hollenbach J., HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007 70 6 455 463 2-s2.0-35948968900 10.1111/j.1399-0039.2007.00932.x (Pubitemid 350075785)
10. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
11. Berasain C., Castillo J., Perugorria M. J., Latasa M. U., Prieto J., Avila M. A., Inflammation and liver cancer: new molecular links. Annals of the New York Academy of Sciences 2009 1155 206 221 2-s2.0-61649106928 10.1111/j.1749-6632.2009.03704.x
12. Lanier L. L., NK cell recognition. Annual Review of Immunology 2005 23 225 274 (Pubitemid 40563170)
13. Gumperz J. E., Litwin V., Phillips J. H., Lanier L. L., Parham P., The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. Journal of Experimental Medicine 1995 181 3 1133 1144 2-s2.0-0028897989 10.1084/jem.181.3.1133
14. Stern M., Ruggeri L., Capanni M., Mancusi A., Velardi A., Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood 2008 112 3 708 710 2-s2.0-50549100480 10.1182/blood-2008-02-137521
15. Chewning J. H., Gudme C. N., Hsu K. C., Selvakumar A., Dupont B., KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. Journal of Immunology 2007 179 2 854 868 2-s2.0-34548732683
16. Foley B., De Santis D., Lathbury L., Christiansen F., Witt C., KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. International Immunology 2008 20 4 555 563 2-s2.0-41149137750 10.1093/intimm/dxn013 (Pubitemid 351426049)
17. Hansasuta P., Dong T., Thananchai H., Weekes M., Willberg C., Aldemir H., Rowland-Jones S., Braud V. M., Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. European Journal of Immunology 2004 34 6 1673 1679 2-s2.0-3242727932 10.1002/eji.200425089 (Pubitemid 39256049)
18. Thielens A., Vivier E., Romagné F., NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Current Opinion in Immunology 2012 24 2 239 245 2-s2.0-84859159747 10.1016/j.coi.2012.01.001
19. Kusnierczyk P., Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Frontiers in Immunology 2013 4, article 8
20. Pan N., Jiang W., Sun H., Miao F., Qiu J., Jin H., Xu J., Shi Q., Xie W., Zhang J., KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS ONE 2011 6 10 2-s2.0-80053592374 10.1371/journal.pone.0025682 e25682
21. Pan N., Chen K., Qiu J., Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients. Human Immunology 2013 74 6 758 763
22. Hsu K. C., Liu X., Selvakumar A., Mickelson E., O'Reilly R. J., Dupont B., Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of Immunology 2002 169 9 5118 5129 2-s2.0-0036839601 (Pubitemid 35217181)
23. Dunn P. P. J., Cox S. T., Little A., Sequencing protocols for detection of HLA class I polymorphism. Methods in Molecular Biology 2003 210 191 222 2-s2.0-1842844011
24. Helmberg W., Dunivin R., Feolo M., The sequencing-based typing tool of dbMHC: typing highly polymorphic gene sequences. Nucleic Acids Research 2004 32 W173 W175 2-s2.0-3242886601 10.1093/nar/gkh424 (Pubitemid 38997323)
25. Jiang W., Zhang J. Q., Pan N., Xu J. H., Xie W., Identification of a novel HLA-A allele, HLA-A9216. Tissue Antigens 2008 71 5 479 480 2-s2.0-42149152244 10.1111/j.1399-0039.2008.01028.x (Pubitemid 351537553)
26. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061 (Pubitemid 46890874)
27. Gao S., Yang W., Bray F., Va P., Zhang W., Gao J., Xiang Y., Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. European Journal of Epidemiology 2012 27 1 39 46 2-s2.0-84857993173 10.1007/s10654-011-9636-8
28. China MoHotPsRo, Diagnosis, management, and treatment of hepatocellular carcinoma (v2011). Journal of Clinical Hepatology 2011 16 10 1141 1159
29. Doo E. C., Hoofnagle J. H., Rodgers G. P., NIH consensus development conference: management of hepatitis B. Introduction. Hepatology 2009 49 5 supplement S1 S3 2-s2.0-66149170350
30. Bruix J., Sherman M., Management of hepatocellular carcinoma. Hepatology 2005 42 5 1208 1236 2-s2.0-28844480321 10.1002/hep.20933 (Pubitemid 43112690)
31. Hong H. A., Loubser A. S., de Assis Rosa D., Naranbhai V., Carr W., Paximadis M., Lewis D. A., Tiemessen C. T., Gray C. M., Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reaction. Tissue Antigens 2011 78 3 185 194 2-s2.0-79960993437 10.1111/j.1399-0039.2011.01749.x
32. Taylor B. C., Yuan J., Shamliyan T. A., Shaukat A., Kane R. L., Wilt T. J., Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence. Hepatology 2009 49 5 supplement S85 S95 2-s2.0-66149181898 10.1002/hep.22929
33. Chen C., Yang H., Su J., Jen C., You S., Lu S., Huang G., Iloeje U. H., Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA Level. Journal of the American Medical Association 2006 295 1 65 73 2-s2.0-29944436855 10.1001/jama.295.1.65 (Pubitemid 43042691)
34. McMahon B. J., Holck P., Bulkow L., Snowball M., Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Annals of Internal Medicine 2001 135 9 759 768 2-s2.0-0035818616 (Pubitemid 33051260)
35. Chan H. L.-Y., Hui A. Y., Wong M. L., Tse A. M.-L., Hung L. C.-T., Wong V. W.-S., Sung J. J.-Y., Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004 53 10 1494 1498 2-s2.0-4644219526 10.1136/gut.2003.033324 (Pubitemid 39265273)
36. Livingston S. E., Simonetti J. P., McMahon B. J., Bulkow L. R., Hurlburt K. J., Homan C. E., Snowball M. M., Cagle H. H., Williams J. L., Chulanov V. P., Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. Journal of Infectious Diseases 2007 195 1 5 11 2-s2.0-33845636202 10.1086/509894 (Pubitemid 44958221)
37. Tong M. J., Blatt L. M., Kao J., Cheng J. T., Corey W. G., Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver International 2007 27 10 1356 1363 2-s2.0-36348986710 10.1111/j.1478-3231. 2007.01585.x (Pubitemid 350142249)